CANY
DXCM icon

Caxton Associates (New York)’s DexCom DXCM Stock Holding History

Caxton Associates (New York)’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$23.3M Buy
+300,000
New +$22.2M 0.73% 22
2022
Q1 		– Sell
-10,140
Closed -$1.36M – 562
2021
Q4 		$1.36M Buy
+10,140
New +$1.46M 0.14% 71
2020
Q4 		– Sell
-3,840
Closed -$396K – 184
2020
Q3 		$396K Buy
+3,840
New +$401K 0.04% 142
2020
Q2 		– Sell
-8,020
Closed -$540K – 506
2020
Q1 		$540K Buy
+8,020
New +$499K 0.1% 146

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Caxton Associates (New York)'s DXCM Position: Q4 2024 in Review

Caxton Associates (New York) opened a new position in DexCom (DXCM) in Q4 2024: 300,000 shares worth $23.3M. The stake represents 0.73% of the portfolio and ranks #22 among its holdings. This is a return to the name: Caxton Associates (New York) previously reported a position in DXCM as recently as Q4 2021.

Caxton Associates (New York) first reported a position in DXCM in Q1 2020 and has held it in 4 quarters since. 950 funds tracked by Wall St. Rank hold DXCM as of Q4 2024.

  • Caxton Associates (New York) held 300,000 shares of DexCom worth $23.3M as of Q4 2024.
  • DexCom was a new Caxton Associates (New York) position in Q4 2024.
  • DexCom made up 0.73% of Caxton Associates (New York)'s portfolio in Q4 2024, its #22 holding.
  • Caxton Associates (New York) first reported a position in DexCom in Q1 2020 and has held it in 4 quarters since.
  • 950 funds tracked by Wall St. Rank held DexCom as of Q4 2024.

Based on Caxton Associates (New York)'s 13F filing for Q4 2024, filed 14 Feb 2025.